Sellas Life Sciences Shares Rise 5% to $10.49
Sellas Life Sciences shares rose 5% on Monday to $10.49, ending a three-session losing streak. Retail investors also discussed potential buyout scenarios after CEO Angelos Stergiou marked the company’s 15th anniversary.
Retail investors in Sellas Life Sciences (SLS) are discussing potential multibillion-dollar buyouts and sharp share-price increases after CEO Angelos Stergiou marked the company’s 15th anniversary in a post referring to its “next chapter.” SLS shares rose 5% on Monday to $10.49, ending a three-session losing streak.